about
Impact of the 2009 influenza A H1N1 pandemic on invasive pneumococcal disease in adults.Diversity of pneumococcal surface protein A (PspA) among prevalent clones in SpainEpidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases.Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems.New species genetic approach to identify strains of mitis group streptococci that are donors of rifampin resistance to Streptococcus pneumoniae.Serotype and genotype replacement among macrolide-resistant invasive Pneumococci in adults: mechanisms of resistance and association with different transposons.New mutations and horizontal transfer of rpoB among rifampin-resistant Streptococcus pneumoniae from four Spanish hospitalsClinical features, etiology and outcomes of community-acquired pneumonia in patients with chronic obstructive pulmonary disease.Invasive pneumococcal disease in healthy adults: increase of empyema associated with the clonal-type Sweden(1)-ST306.Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): implications for future vaccination strategies.Spread of Streptococcus pneumoniae serotype 8-ST63 multidrug-resistant recombinant Clone, SpainClinical and molecular epidemiology of haemophilus influenzae causing invasive disease in adult patients.Disease isolates of Streptococcus pseudopneumoniae and non-typeable S. pneumoniae presumptively identified as atypical S. pneumoniae in SpainSome pneumococcal serotypes are more frequently associated with relapses of acute exacerbations in COPD patients.Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates.Increase in bloodstream infection due to vancomycin-susceptible Enterococcus faecium in cancer patients: risk factors, molecular epidemiology and outcomes.Experimental study of LY333328 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitisCharacterization of invasive Pneumococci of serogroup 6 from adults in Barcelona, Spain, in 1994 to 2008.Molecular epidemiology of nontypeable Haemophilus influenzae causing community-acquired pneumonia in adults.Induction of prophages by fluoroquinolones in Streptococcus pneumoniae: implications for emergence of resistance in genetically-related clones.Emerging, Non-PCV13 Serotypes 11A and 35B of Streptococcus pneumoniae Show High Potential for Biofilm Formation In Vitro.Auranofin efficacy against MDR Streptococcus pneumoniae and Staphylococcus aureus infections.Carbapenem-resistant and carbapenem-susceptible isogenic isolates of Klebsiella pneumoniae ST101 causing infection in a tertiary hospital.Emergence of Amoxicillin-Resistant Variants of Spain9V-ST156 Pneumococci Expressing Serotype 11A Correlates with Their Ability to Evade the Host Immune ResponseIdentification of Haemophilus haemolyticus in clinical samples and characterization of their mechanisms of antimicrobial resistance.Fluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae clones, Spain.Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center.Bacterial Lysis through Interference with Peptidoglycan Synthesis Increases Biofilm Formation by Nontypeable Haemophilus influenzaeBronchial microbiome, PA biofilm-forming capacity and exacerbation in severe COPD patients colonized by P. aeruginosa.Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain.Pneumococci can persistently colonize adult patients with chronic respiratory diseaseSerotype 5 pneumococci causing invasive pneumococcal disease outbreaks in Barcelona, Spain (1997 to 2011).Evolution and genetic diversity of the Spain23F-ST81 clone causing adult invasive pneumococcal disease in Barcelona (1990-2012).Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period.What is the clinical relevance of drug-resistant pneumococcus?Incorporation of phosphorylcholine into the lipooligosaccharide of nontypeable Haemophilus influenzae does not correlate with the level of biofilm formation in vitro.Novel blaROB-1-bearing plasmid conferring resistance to β-lactams in Haemophilus parasuis isolates from healthy weaning pigsFluoroquinolone-resistant pneumococci: dynamics of serotypes and clones in Spain in 2012 compared with those from 2002 and 2006.A Novel Typing Method for Streptococcus pneumoniae Using Selected Surface Proteins.High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus.
P50
Q30358239-ACF3A8AC-C04B-4D24-9C43-E5C2E0D53D78Q33439975-69CA8F07-5C16-4CFF-9F2C-F04456A286B5Q33690464-183E9C90-3CB9-41F3-8FBF-A5750592A717Q33694016-E42613BA-06A8-4F1B-9136-ED2ABA1E2B38Q33735606-39D771CF-8A6A-40C0-A74B-35281FDF3069Q33769479-96567579-59BE-4BD2-9D5A-BF899CA4B4DAQ33836747-36036A7D-A7DB-4069-906F-AD727579D407Q34105094-F564D142-8187-485C-890D-E0761CE8C680Q34388781-A589E885-4394-49F5-82AC-B0C3B429CA03Q34395856-52DC7142-2B8A-42F2-A8DC-89632EDD6C17Q34426636-E7020681-4C10-4075-B906-F100E092BEFAQ34473400-6C75B23D-6015-4F18-AEA1-71984A097F13Q34599946-1341F5BD-E21D-4AF3-93DB-034F242C34C6Q34639525-B83EFB50-9212-4C0B-96F7-4B8BF48791ECQ34922753-E17F0786-5F45-43DF-B39D-FF5081DCE030Q34999291-E0E3A97A-CCA1-43E3-8D80-C5616ECF0353Q35013994-A8646E08-6F6C-4937-A112-D12DEAA87A81Q35066853-0B4C3384-F034-4963-A9CD-30AC87CAA6C4Q35070330-25BB3F2F-75CC-4DF1-A772-D9761A65AF5BQ35144206-9CAB2C9E-0AA9-43F2-9B2C-62784E89A112Q35619025-BA177BA1-6B8F-46BA-9E54-49E597F7DC09Q35682692-61D322F9-4746-419E-B64A-A367430F1566Q35763406-ACDA3227-410A-406C-A488-B24EF5AF254AQ35773895-DE3F2298-6F1D-4A82-9069-A9FCEAF041F3Q35809852-24579892-EBF2-44E3-B65C-A2F9B7973173Q35880792-95CB864D-3416-43F5-828C-B2E4B6E49010Q36247827-6D1F77CD-3662-4D98-9086-53E4E75B3D0BQ36260636-3C7B2B49-54A8-4671-A3CF-5CE34AE3F738Q36321964-CA268F03-B875-4065-834E-C8F6B6F687BAQ36338543-8B822E85-3AF8-49C0-A184-36F3448CBF00Q36413948-4F7089ED-344F-4975-B8B6-19F7586E7639Q37470328-3A0DFC02-FBA6-430C-BF4A-19BACDCB534EQ37641273-BFE28BA3-73D0-4036-9855-3C35A2D16C94Q37687485-2F994103-556C-440D-A68C-6CD8C110BBBFQ38743919-B39E7D9C-2439-48FC-BDF1-57CB88DAFB9FQ38851861-3BC72333-C308-47F1-9F70-084E71845037Q39519048-E92A7020-67AC-4641-B85A-E1714AC74DF6Q39682438-17448901-DC49-4942-96E2-B06F795B9698Q39716889-969A5099-D7F1-4739-9ACF-53D4E33F6D5CQ39756833-44018A40-D4FE-46E4-8C70-214D019CB2AF
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Carmen Ardanuy
@ast
Carmen Ardanuy
@en
Carmen Ardanuy
@es
Carmen Ardanuy
@nl
Carmen Ardanuy
@sl
type
label
Carmen Ardanuy
@ast
Carmen Ardanuy
@en
Carmen Ardanuy
@es
Carmen Ardanuy
@nl
Carmen Ardanuy
@sl
prefLabel
Carmen Ardanuy
@ast
Carmen Ardanuy
@en
Carmen Ardanuy
@es
Carmen Ardanuy
@nl
Carmen Ardanuy
@sl
P214
P106
P1580
P21
P214
P31
P496
0000-0003-0225-607X
P734
P735
P7859
viaf-316756572